Bioprocess Engineering, Faculty III Process Sciences, Institute of Biotechnology, Technische Universität Berlin (TU Berlin), Berlin, Germany.
DataHow AG, Zurich, Switzerland.
Adv Biochem Eng Biotechnol. 2021;177:1-28. doi: 10.1007/10_2020_154.
Typically, bioprocesses on an industrial scale are dynamic systems with a certain degree of variability, system inhomogeneities, and even population heterogeneities. Therefore, the scaling of such processes from laboratory to industrial scale and vice versa is not a trivial task. Traditional scale-down methodologies consider several technical parameters, so that systems on the laboratory scale tend to qualitatively reflect large-scale effects, but not the dynamic situation in an industrial bioreactor over the entire process, from the perspective of a cell. Supported by the enormous increase in computing power, the latest scientific focus is on the application of dynamic models, in combination with computational fluid dynamics to quantitatively describe cell behavior. These models allow the description of possible cellular lifelines which in turn can be used to derive a regime analysis for scale-down experiments. However, the approaches described so far, which were for a very few process examples, are very labor- and time-intensive and cannot be validated easily. In parallel, alternatives have been developed based on the description of the industrial process with hybrid process models, which describe a process mechanistically as far as possible in order to determine the essential process parameters with their respective variances. On-line analytical methods allow the characterization of population heterogeneity directly in the process. This detailed information from the industrial process can be used in laboratory screening systems to select relevant conditions in which the cell and process related parameters reflect the situation in the industrial scale. In our opinion, these technologies, which are available in research for modeling biological systems, in combination with process analytical techniques are so far developed that they can be implemented in industrial routines for faster development of new processes and optimization of existing ones.
通常情况下,工业规模的生物工艺是具有一定可变性、系统非均一性甚至种群异质性的动态系统。因此,将这些工艺从实验室规模放大到工业规模,或者反之,并非易事。传统的降尺度方法考虑了几个技术参数,因此,实验室规模的系统往往在定性上反映了大规模的影响,但不能反映工业生物反应器在整个过程中的动态情况,从细胞的角度来看。随着计算能力的巨大提高,最新的科学重点是应用动态模型,并结合计算流体动力学来定量描述细胞行为。这些模型允许描述可能的细胞生命线,进而可以用于为降尺度实验推导一个状态分析。然而,迄今为止所描述的方法,虽然针对非常少的过程示例,但非常耗费人力和时间,并且不容易验证。与此同时,还基于混合过程模型对工业过程进行描述,开发了替代方法,这些模型尽可能地对过程进行机理描述,以确定具有各自方差的基本过程参数。在线分析方法允许直接在过程中对种群异质性进行表征。可以将这些来自工业过程的详细信息用于实验室筛选系统,以选择相关条件,使细胞和过程相关参数反映工业规模的情况。在我们看来,这些在生物系统建模研究中可用的技术,结合过程分析技术,已经发展到可以在工业常规中实施,以加快新工艺的开发和现有工艺的优化。